Cardiovascular Function and Treatment in Beta-Thalassemia Major
Published: June 17, 2013
![Science News on light gray background](/-/media/PHD-Images/Science-News/science_news_default.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- Heart failure (HF) is the most common cause of death in Thalassemia Major.
- In patients with Beta-thalassemia Major, acute and chronic forms of heart failure require different treatment.
- Life expectancy is extended with use of chelation therapy.